Nishikawa G. et al. reported that MSCs promote CRC progression through C-C chemokine receptor type 5 (CCR5) ligands, such as C-C motif chemokine ligand 3 (CCL3), CCL4 and CCL5. This evidence concerns the gene CCR5 and colorectal carcinoma.